A lower Apnea-Hypopnea Index, diabetes, alcohol consumption, divorced status, baseline excessive daytime sleepiness complaint and lower CPAP use at discharge were identified as independent predictors for CPAP non-compliance one year after discharge.
Among the physiological parameters recorded during PAP titration, the lowest SpO2 was the most robust predictor of short-term adherence, independent of both baseline disease severity and baseline hypoxemia.
It is suggested that low SOC is a risk factor for non-adherence to treatment and is a key clinical predictor for developing motivational strategies to improve treatment persistence in patients with OSA.
Monserrat Gómez Juárez, Fátima K. Gaytán Núñez, Francisco Vargas Hernández et al.· Cureus· 0 citations
Obstructive sleep apnea (OSA) is a prevalent sleep-related breathing disorder characterized by recurrent upper airway collapse. Continuous positive airway pressure (CPAP) is the gold standard treatment but is burdened by low adherence rates. Nighttime hypoxia may alter sleep structure and OSA symptoms, potentially affe...
Andrea Portacci, S. Quaranta, C. Santomasi et al.· Clocks & Sleep· 0 citations
Introduction: Obstructive sleep apnea (OSA) is a frequently underdiagnosed condition characterized by symptoms such as excessive daytime sleepiness, fatigue, and reduced quality of life (QoL), while continuous positive airway pressure (CPAP) is the gold standard treatment. This study aimed to examine the impact of CPAP...
Ksenija Ćurić, Vlasta Pekić, Jelena Šarić Jurić et al.· Nursing evidence and care· 0 citations
Obstructive sleep apnea (OSA) is highly prevalent among patients with stroke and transient ischemic attack (TIA) and is associated with poor outcomes including post-stroke depression. Continuous positive airway pressure (CPAP) is the standard treatment for OSA, however, adherence is low. The relationship between CPAP a...
Hephzibah O. Ali, Michelle Gyenes, Henry T. H. Xie et al.· Sleep Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.